Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
USE OF RASAGILINE WITH RILUZOLE TO TREAT AMYOTROPHIC LATERAL SCLEROSIS
No-Receipt date
2013-03087 - 08/10/2013
No-Filing date
20130402061 - 08/10/2013
No-Granting date
3081810 - 11/10/2013
No-EPO application date
03783422.3 - 13/11/2003
No-EPO granting date
1567152 - 14/08/2013
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2013 - 18/11/2013
Expiration date
14/11/2023
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US426543 P15/11/2002/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/135
A61K 31/425
A61K 31/428
A61P 25/28
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
498336
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
5 BASEL STREET, BOX 3190
PETAH TIKVAH 49131
ISRAEL
Inventors
Code
Firstname
Surname
1192651
BLAUGRUND, ERAN
1192652
LEVY, RUTH
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8397
ANDRONIKI
MISIOU
ANALIPSEOS 23 KAI MARATHONOS 27
VRILISSIA (ATTIKIS)
15235
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
6/5/2019 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 05/2019 - Αρ. Πρωτ. ΓΔ 1194 / 05-06-2019 (Κανονικά στο number έπρεπε να εισαχθεί 11949 αλλά λόγω του ότι προυπήρχε εισήχθη 1194 δηλαδή ο αριθμός πρωτοκόλλου χωρίς ένδειξη έτους)
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).